The objective of this study was to investigate the vascular status, left-ventricular mass and biomarkers of endothelial activation in hypertensive (HT) adolescents, with particular attention to comparing nonobese with obese patients. Seventy-nine newly diagnosed HT adolescents aged 15.1±2.1 years (divided into 34 nonobese and 45 obese) were compared with 35 healthy volunteers. Intima --media thickness (IMT), flow-mediated dilation (FMD) and left-ventricular mass index (LVMi) were determined using ultrasound. Adhesion molecules and inflammatory interleukins (ILs), together with lipids and insulin resistance (HOMA), were also studied. HT obese adolescents had higher triglycerides, HOMA, and elevated levels of interleukin-6, tumor necrosis factor-a, soluble intercellular adhesion molecule-1 and soluble E-selectin compared with controls and nonobese HT patients. FMD was lower in HT groups (8.5 ± 4.5% in nonobese, P ¼ 0.004; 8.1 ± 4.9%, P ¼ 0.01 in obese vs 12.5 ± 4.9%; in control), and IMT was higher (0.52 ± 0.06 mm, Po0.001 in nonobese; 0.54 ± 0.05 mm, Po0.001 in obese vs 0.42 ± 0.05 mm in control). Higher LVMi was found in both HT groups, with the highest value in the nonobese group being 37.8±5.3 g m À2.7 vs 28.4±5.3 g m À2.7
INTRODUCTION
Cardiovascular disease (CVD) caused by atherosclerosis has become a serious health epidemic. The preclinical phase of the disease may last for several decades, thereby providing the possibility of detecting the disease as early as in the presymptomatic phase in childhood. 1 CVDs are associated with number of risk factors, such as hypertension, which is a leading cause of cardiovascular morbidity and mortality in adults. 2 Risk factors for CVDs present in childhood persist into adulthood. 3 Specifically, elevations in blood pressure during growth have been shown to predict the presence of hypertension in adulthood. 4 Published data show that atherosclerosis, arterial stiffness, endothelial dysfunction and left-ventricular hypertrophy can emerge in childhood and adolescence, and elevated blood pressure predicts them all. 5 --7 Thus, a recent report suggesting that pediatric hypertension often goes underdiagnosed appears to be extremely important. 8 In recent years, numerous novel markers of atherosclerosis, endothelial activation and low-grade inflammation, and methods of its early diagnosis have been researched, even in children. 9 Using high-resolution vascular ultrasound-based tests of endothelial function, including the vasodilator response to increased blood flow (flow-mediated vasodilatation (FMD)), the analysis of carotid artery intima --media thickness (IMT) and echocardiographic assessment of left-ventricular mass (LVM) and/or hypertrophy can now be accomplished. 1 In concert with the increasing prevalence of obesity in children, pediatric hypertension has undergone an epidemiological shift. The commonly held notion suggests that hypertension in children is a relatively rare condition most commonly associated with renal disease. In fact, secondary hypertension in children has become far less common than that related to primary hypertension. 10 Furthermore, body mass index (BMI) is consistently and independently related to BP levels in children; that is, overweight and obesity considerably increase the risk of hypertension. 11 Obesity hypertension is complex, multifactorial and strongly associated with CVDs. 12 In our previous studies, we showed the associations between inflammatory markers of the endothelium, impaired FMD and increased IMT in obese hypertensive (HT) children and adolescents. 13 Many studies, performed so far, have been confounded by a high proportion of HT subjects with obesity being regarded as an independent risk factor for CVDs. Consequently, even after adjusting for BMI, previous studies have been inconsistent in showing increased cardiovascular involvement in HT children. 14, 15 No studies have been done, so far, to evaluate simultaneously the levels of endothelial markers of activation, inflammation and ultrasonographic determinants of endothelial dysfunction (FMD), structural changes of carotid IMT and LVM in primary HT adolescents in relation to the presence or absence of obesity.
Therefore, the aim of this study was to investigate circulating biomarkers of cardiovascular disease (soluble intercellular adhesion molecule-1 (sICAM-1), soluble E-selectin (sE-selectin), interleukin-6 (IL-6), tumor necrosis factor-a (TNF-a)), and ultrasonographic measures of early atherosclerosis (FMD, IMT, LVM) in obese vs nonobese adolescents with primary hypertension. We hypothesized that nonobese adolescents with hypertension demonstrated lower intensity of early atherosclerosis changes than those with obesity and coincident HT.
MATERIALS AND METHODS

Study participants
Newly diagnosed, untreated HT subjects were recruited from among children who were referred to the Department of Pediatrics, Endocrinology, Diabetology with Cardiology Division, Medical University of Bialystok (Poland), owing to elevated blood pressure values. This group consisted of 79 patients, aged 15.1 ± 2.1 years, who were divided according to their BMI into 34 nonobese HT and 45 obese HT adolescents. The inclusion criteria were: age over 10 years, primary hypertension, normal clinical examination and no evidence of infection 3 weeks before the study; cases with endocrine, renal or cardiac causes of hypertension were excluded.
Hypertension was diagnosed according to the recommendations of the Second Task Force on Blood Pressure in Children. All subjects had office systolic and/or diastolic BP X95th percentile for age, gender and height on X3 occasions. The diagnosis of hypertension was then confirmed by 24-h ambulatory monitoring (ABPM), in which HT was defined as average daytime and/or nighttime BP X95th percentile for gender and height relative to ABPM pediatric reference, and systolic blood pressure (SBP) load above 25% using the Spacelab device (Spacelab Cardio Navigator, Spacelabs Healthcare, Issaquah, WA, USA). 16, 17 Weight and height were measured by a trained staff person using standard methods and calibrated equipment, with intra-observer variation being less than 0.9% based on 24 duplicated measurements of the study subjects. Obesity was defined as a BMI (kg m
À2
) exceeding the 95th percentile, according to age and gender, using national Polish percentile growth charts. 18 Children with secondary obesity were excluded from the study.
The control group included 35 healthy normotensive volunteers, aged 15.1±1.2 years. The inclusion criteria for the control group were: blood pressure values below the 90th percentile according to age, sex and height, BMI below the 95th percentile or negative family history of CVD among first-degree relatives. Control patients were recruited from among children who were admitted to the clinic owing to minor cardiological problems, without any significant findings in cardiological examination. The description of the groups is presented in Table 1 . As sex distribution differed between the groups (that is, more males were included into the nonobese HT group) all comparisons were adjusted for sex.
Laboratory investigations
A blood sample of 10 ml was taken from the left cubital vein in the morning before breakfast, after an overnight (8 --12 h) fast. To assess adhesion molecules and inflammatory markers, serum samples were collected, frozen and stored at a temperature of À80 1C until analyses were performed. The concentrations of sICAM, sE-selectin, IL-6 and TNF-a were determined immunoenzymatically using commercially available ELISA kits (Parameter Human Immunoassays, R&D Systems, Inc., Minneapolis, MS, USA) with the aid of an ELx 800 Automated Microplate Reader (Bio-Tek Instruments, Winooski, VT, USA). Concentrations of lipid, glucose and insulin parameters were determined by the standard enzymatic methods (Hitachi 912, La Roche, Japan). Low-density lipoprotein concentration was assessed by the Friedewald equation. The homeostasis model was used to assess insulin resistance (HOMA IR) derived from the following formula: insulin resistance (HOMA IR) ¼ (fasting insulin (mU ml À1 ) Â fasting glucose (mmol Àl ))/22.5.
Ultrasound measurements
All children were examined in a quiet, temperature-controlled room. The procedure was conducted between 0800 and 1000 hours after a fasting period of 8 --12 h. Examinations of the brachial and carotid arteries were performed by means of the apparatus of Hewlett Packard Sonos 4500, using a 7.5-MHz linear transducer. Ultrasound examination of the brachial arteries was performed in longitudinal sections 2 --10 cm above the elbows according to actual guidelines. 19 The principle is to induce enhanced flow in the proximal (brachial) artery by postischemic (forearm) vasodilatation. All lumen-diameter measurements were scanned at the end diastole by using the R-wave of the electrocardiogram. First scans were taken at rest, and second scans during reactive hyperemia. Increased flow was induced by deflating a pneumatic tourniquet placed on the right forearm, inflated to the pressure of 300 mm Hg for 4 min. The postischemic scan was performed 45 --60 s after cuff deflation. FMD was derived from the percentage change of the brachial-artery diameter after ischemia of the forearm from baseline. Measurements of intima plus medial thickness in the common carotid arteries (right and left)---the value of IMT---were performed as previously described, with own modification. 13, 20 Briefly, measurements included end-diastolic (minimum diameter) IMT of the far walls (the distance from the leading edge of the first echogenic line to the leading edge of the second echogenic line), at a distance of more than 1 cm from the bifurcation. Analyses included the mean value of six measurements. No carotid plaques were found in either of the children under study.
All the participants underwent a complete two-dimensional echocardiogram with M-mode and Doppler study. All of them had structurally normal heart. Measurements of the LV internal dimension, interventricular septal thickness and posterior-wall thickness were made during diastole according to the practice guidelines of the American Society of Echocardiography. Left-ventricular mass index (LVMi) was calculated by dividing the LVM by height in meters raised to the power of 2.7 to minimize the effect of age, gender and body weight, according to the de-Simone formula. 21, 22 All examinations were carried out and analyzed by one experienced pediatric vascular ultrasonographer, who was blinded to the participants' cardiovascular risk-factor status. The intra-observer variability was 2.5% for FMD and 3.2% for IMT (evaluated in a subset of patients, n ¼ 20).
We obtained approval from the Ethical Committee of the Medical University of Bialystok. Both parents/legal guardians and children gave their written informed consent.
Statistical analyses
All statistical analyses were undertaken with the Statistica 9.0 software (StatSoft, Inc., Cracow, Poland). The Kolmogorov --Smirnov test was used to test the distribution normality. Homogeneity of variance was checked with Levene's test. Differences between group means were tested for significance using a one-way analysis of variance (ANOVA) and post-hoc Bonferroni method for multiple comparisons of parametric variables. For comparison of three groups of nonparametric variables, the Kruskal --Wallis test was used with multiple-comparison procedures (Dunn's method). Pearson's correlation analysis was performed for variables with normal distribution and Spearman's correlation analysis was used for non-normal distribution. In order to detect the independent determinants of FMD, IMT and LVMi, multivariable linear regression analysis was performed, separately for both groups of nonobese and obese patients. Only variables for which the P value in a univariate analysis was o0.15 were included in these models. These data were presented as mean and standard deviation. A P-value o0.05 was considered statistically significant.
RESULTS
General data and arterial blood pressure results are presented in Table 1 . Both HT groups had higher blood pressure values, with obese HT presenting the highest (but not significantly) values, compared with nonobese HT.
In the studied lipid parameters, we found significant differences in triglyceride (TG) levels. Both the studied groups of HT adolescents had higher TG than controls. The difference was also significant between both HT groups (Po0.001). Fasting insulin and insulin-resistance index (HOMA IR) were markedly higher in the obese HT group, compared with control and to nonobese HT. In nonobese HT adolescents, glucose-metabolism parameters were similar to those in the control group (Table 1) .
Plasma biomarkers
We found several significant differences in the studied plasma biomarkers of endothelial activation and low-grade inflammation. For sICAM-1 the level in HT nonobese and HT obese groups was significantly higher compared with the control group, and the difference was also found between both HT groups. sE-selectin level was higher only in obese HT adolescents (P ¼ 0.004) as compared with controls, and with HT nonobese adolescents (P ¼ 0.020). In the group of obese HT adolescents, we also found differences in IL-6 (P ¼ 0.005 vs controls, P ¼ 0.010 vs nonobese HT) and TNF-a (P ¼ 0.010 vs controls and vs nonobese HT). The results of these parameters demonstrate that endothelial activation and inflammation, based on plasma biomarkers, are more pronounced in the obese HT group of adolescents (Table 1) .
Ultrasonographic studies FMD was lower in nonobese HT (8.5±4.5%, P ¼ 0.004) and obese HT (8.1±4.9%, P ¼ 0.010) groups as compared with controls (12.5 ± 4.9%). FMD within the two HT groups was similar. IMT in the nonobese HT group was 0.52 ± 0.06 mm, Po0.001, and in the obese HT group was 0.54±0.05, Po0.001 as compared with controls (0.42±0.05 mm). Although IMT was highest in the obese HT group, the difference between nonobese and obese groups was not significant. HT patients had higher LVMi than controls, with the highest value in the nonobese HT group being 37.8±5.3 vs 28.4 ± 5.3 g m À2.7 in the control group (P ¼ 0.003), and that in the obese HT group being 35.4 ± 6.6 g m
À2.7
, P ¼ 0.005. As in previous comparisons, the difference between the two HT groups was not significant. Early atherosclerotic changes in ultrasonographic evaluation were markedly elevated in all HT adolescents when compared with the control group, but were comparable in HT nonobese vs obese adolescents (Figure 1 ).
Correlations
We found several inverse correlations in the obese HT group: between FMD and BMI, SDS --BMI, SBP, diastolic blood pressure, HOMA, TNF-a and sICAM-1. Significant positive correlations between IMT and BMI, SDS --BMI, SBP, diastolic blood pressure, triglycerides, HOMA, sICAM-1 and sE-selectin were found. LVMi showed positive correlation with TNF-a and sICAM-1. In the nonobese HT group, significant correlations were found between FMD and SBP and sICAM-1 (inverse), and between IMT and BMI, SDS --BMI, SBP and diastolic blood pressure (positive). LVMi correlated with BMI, SBP and triglycerides (Table 2) .
In multivariate regression models involving obese HT adolescents, IMT was associated with BMI, SBP, HOMA index and sICAM-1 (R 2 ¼ 0.49, B ¼ 0.15, Po0.001) and FMD was dependent on BMI, SBP and TNF-a (R 2 ¼ 0.44, B ¼ 0.29, P ¼ 0.020). In nonobese HT adolescents, IMT was associated with SBP and triglycerides; however, the model explained only 31% of the variance in IMT. Despite some significant correlations in univariate analysis, regression analysis using markers of cardiovascular risk did not allow to build any other model explaining the variability of FMD or LVMi in the nonobese group.
DISCUSSION
Children with primary hypertension are frequently overweight. Consequently, most of the previous studies comparing cardiovascular risk between HT and healthy children reported a disproportionately higher proportion of children with obesity among HT groups. The current study was designed to compare the cardiovascular risk profile between HT obese and HT nonobese adolescents, considering the commonly held view that those without obesity usually gain less interest regarding increased cardiovascular risk. In our study, we estimated lipids, glucose/insulin parameters and several biomarkers of athero-sclerosis including endothelial activation and inflammation, together with non-invasive, ultrasonographic examination of early atherosclerosis deterioration (IMT, FMD, LVMi). The main finding of our study is that obese HT adolescents presented more alterations in plasma lipids, insulin resistance, and elevated levels of adhesion molecules and inflammatory markers, suggesting greater cardiovascular risk; however, ultrasonographic evaluation revealed similar early atherosclerotic changes in the nonobese HT subjects. These data suggest that this group of young patients, irrespective of more favorable plasma results, have the same cardiovascular risk as their obese HT peers.
Ultrasonographic measures of early cardiovascular changes
In adults, increased IMT is an indicator of generalized atherosclerosis and a strong predictor of future cardiovascular events. 23 Several reports have shown an increased IMT in childhood diseases such as diabetes or familial hypercholesterolemia. IMT in HT and obese children and adolescents has relatively recently become a focus of interest. 14, 15, 24, 25 Lande et al. compared obese HT children with obese normotensive controls. They proved increased IMT in HT children, independently of the effect of obesity.
14 In non-HT children, IMT is also associated with blood pressure. 26 The results of our study consistently confirmed previous studies, but we further proved that HT nonobese children have as increased an IMT as obese ones.
Increased LVM, which is regarded as the best marker of cardiovascular end-organ damage, is present in approximately 40% of the HT children. 27, 28 In addition, 55% of the children with persistent BP elevations may have a LVMi 490 percentile, with over 10% of those having a LVMi 451 g m À2.7 , a value carrying nearly fourfold greater risk of cardiovascular events in adults with hypertension. 22 The National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents recommended that echocardiograms should be obtained as part of the initial evaluation of children with evidence of hypertension. It is further recommended that LVH infers a need for intensified antihypertensive therapy. In our study, nonobese HT patients had the greatest value of LVMi, proving their high risk for cardiovascular system damage. 16 The evaluation of brachial artery endothelial function (FMD) is now increasingly used for pediatric cardiovascular risk evaluation. Several studies performed so far focused mainly on childhood obesity. 5, 13, 29, 30 Endothelial dysfunction appeared to be the first marker of atherosclerosis in obese children as it was revealed even in the prepubertal period, though without structural changes in IMT. 5 Furthermore, impaired endothelial function in childhood obesity correlates with blood pressure, which remains consistent with the results of the present study. 5, 29 Our report confirms a deteriorated endothelial function in obese adolescents, but we extend this observation by showing similar dysfunction in nonobese HT patients.
Plasma biomarkers of atherosclerosis
The presence of inflammation is regarded as an important factor in the pathogenesis of atherosclerosis. The main inflammatory markers used for the evaluation of atherosclerosis are CRP, IL-1, IL-6, IL-18 and TNF-a. 31 The most extensively studied biomarker of inflammation in cardiovascular disease is CRP, the pathogenic importance of which in childhood obesity has already been proved. 32 In this study, other inflammatory particles---IL-6 and TNF-a---were examined together with the so-called markers of endothelial activation, selected adhesion molecules. We found increased levels of these markers mainly in obese HT patients, providing further evidence, that adipose tissue, even during early growth, may be associated with low-grade inflammation. Vascular changes in our study groups were related to plasma markers of endothelial activation and inflammation. Other studies reported IMT in obese children to be associated with CRP level. 33 A higher level of CRP, together with lower FMD value, has been demonstrated in recent studies of children at risk for overweight (BMI between 85th and 95th percentiles). 34 The causal pathways of our findings are difficult to elucidate as no similar studies have been performed so far. Primary hypertension is a complex disease consisting of both metabolic and hemodynamic abnormalities, while the underlying mechanisms in nonobese individuals may be independent of metabolic alterations in fat tissue. Our previous studies suggested that family history of hypertension was found in 72%, and family history of premature cardiovascular disease in 19% of HT nonobese adolescents. 35 Family history of hypertension may be associated with an initial increase in inflammation markers and plaque instability in otherwise healthy young normotensive individuals. 36 There is a possibility that genetic predisposition for early atherosclerosis may be liable to the vascular abnormalities found in nonobese HT. On the other hand, some lifestyle factors, other than obesity, for example high-salt diet, poor sleep quality or sedentary behaviors, are also regarded as important contributors of childhood primary hypertension. 37, 38 We did not evaluate those possible associations in our study; neither were measurements of microalbuminuria, a known risk factor of atherosclerosis, performed. Recent data show that microalbuminuria is also a strong predictor of LVH in hypertension during growth, that is, reduced microalbuminuria delays progression of LVH. 39 The authors of that study underscore that microalbuminuria alone explains 76% of the variance in LVMi. The associations discussed above, though not studied, may have been partly responsible for the clinical manifestation among our patients.
Our findings provide further evidence that primary hypertension in childhood is apparently associated with vascular pathology, independently of the effects of obesity. Thus, more attention should be given to the diagnosis of hypertension in children and adolescents who are not obese. Indeed, nonobese individuals may be omitted in the routine blood-pressure examinations, as they are usually not referred to a thorough examination unless they become obese. The results of our study show that nonobese HT adolescents have impaired endothelial function, increased IMT of carotid arteries and also high LVMi. This suggests the presence of cardiovascular risk, similar to that observed in the obese individuals. In fact, these data fail to support the hypothesis that nonobese adolescents with hypertension have less intensive early atherosclerosis changes than their peers with obesity and coincident HT. Our study points out that particular cardiovascular prevention strategies should be elaborated for these patients. Ultrasonographic evaluation, indicating the presence of early arterial changes, may infer a rationale for identifying high-risk HT children, who are susceptible to early cardiovascular disease. Noticeably, results on soluble plasma markers are not always informative, or are not obviously alarming.
Our study has certain limitations, implicating a careful interpretation of the conclusions, that is, the sample size was relatively small, limiting the power of the analysis or leading to some methodological issues. Furthermore, nonobese HT individuals were included in the analysis on the basis of their having a BMI o95th percentile. This cut-off value means that those with overweight only (that is, BMI between 85th and 95th percentiles) may also have been included. Although these results may be somehow influenced by body-weight classification, our data may still contribute to elucidate the mechanisms of early atherosclerosis and to assess the CVD risk in young, nonobese HT patients.
In conclusion, the potential mechanisms of early atherosclerosis in nonobese HT adolescents need further evaluation in prospective studies because these factors may considerably differ from those found in obese individuals with HT. Hypertension during growth, even without obesity, may be independently associated with an increased risk of atherosclerosis.
What is known about this topic
Body mass index (BMI) is independently associated with blood pressure levels in children, i.e., overweight and obesity considerably increase the risk of hypertension. Early markers of atherosclerosis are increased in hypertensive children and adolescents; however, a vast majority of previously published studies have been confounded by a high proportion of hypertensive subjects with coincident obesity conferring itself an increased risk of cardiovascular disease.
What this study adds Non-obese HT adolescents have the same early cardiovascular deteriorations, assessed with ultrasonography, as their obese hypertensive peers, although metabolic alterations and endothelial activation measured as plasma biomarkers are more pronounced in the obese. Clinicians should focus their attention on identifying cardiovascular risk profile and detecting hypertension also in non-obese individuals during growth. The potential mechanisms of early atherosclerosis in non-obese HT adolescents need further evaluation in prospective cohort studies as these factors may substantially differ from those found in young obese individuals with HT.
